{"id":788171,"date":"2026-07-08T12:14:14","date_gmt":"2026-07-08T12:14:14","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/788171\/"},"modified":"2026-07-08T12:14:14","modified_gmt":"2026-07-08T12:14:14","slug":"researchers-launch-trial-to-see-if-blood-test-can-detect-cancer-left-behind-after-treatment","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/788171\/","title":{"rendered":"Researchers launch trial to see if blood test can detect cancer left behind after treatment"},"content":{"rendered":"<p class=\"c-article-body__text text-pr-5\">Researchers at Princess Margaret Cancer Centre in Toronto are working on a large trial to determine if a blood test can detect tiny amounts of cancer remaining after patients have been treated. <\/p>\n<p class=\"c-article-body__text text-pr-5\">Lead investigator Dr. Lillian Siu says smaller studies around the world have shown evidence that cancer DNA can show up in the blood in amounts too small to be identified by CT scans. <\/p>\n<p class=\"c-article-body__text text-pr-5\">But large-scale studies are needed to prove that so Siu and her team are enrolling 7,000 patients who have completed their radiation, chemotherapy or other cancer treatments and testing their blood to find microscopic quantities of tumour DNA. <\/p>\n<p class=\"c-article-body__text text-pr-5\">If the test \u2013 also known as a liquid biopsy \u2013 is positive, those patients could get additional experimental treatments, such as new immunotherapies, to try to prevent the cancer from coming back. <\/p>\n<p class=\"c-article-body__text text-pr-5\">If the test is negative, Siu said it could show that the cancer is really gone and further sessions of chemotherapy or radiation could be stopped to minimize side-effects from unnecessary treatments.<\/p>\n<p class=\"c-article-body__text mv-16 l-inset text-pb-8\" data-sophi-feature=\"interstitial\"><a href=\"https:\/\/www.theglobeandmail.com\/canada\/article-pancreatic-cancer-drug-daraxonrasib-survival-time\/\" rel=\"nofollow noopener\" target=\"_blank\">Drug that could extend lives of Canadians with pancreatic cancer remains out of reach<\/a><\/p>\n<p class=\"c-article-body__text text-pr-5\">Siu says the trial \u2013 called SHERLOCK \u2013 also aims to find out if the effectiveness of the blood test varies between different cancer types.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Clinicians and researchers have been looking at liquid biopsies to find tiny remnants of cancer left over after treatment \u2013 known as molecular residual disease \u2013 for the past decade, she said. <\/p>\n<p class=\"c-article-body__text text-pr-5\">After collecting blood samples and matching them to whether or not cancer actually returned in patients, there is now a \u201csubstantial amount of data to show that people who have positive molecular residual cancer, their cancer has a very high chance of returning,\u201d said Siu, who is the scientific lead at the hospital\u2019s Peter Gilgan\u202fCentre for Early Cancer Detection Research.<\/p>\n<p class=\"c-article-body__text text-pr-5\">But she emphasized that although promising, blood tests to predict cancer recurrence are \u201cnot standard of care\u201d at this point and SHERLOCK and other clinical trials need to be completed. <\/p>\n<p class=\"c-article-body__text text-pr-5\">The researchers plan to follow the patients for at least five years, Siu said. <\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cYou need to have the long-term follow-up to know whether the test is actually predicting longer-term outcome(s), so just stopping at one year is not going to be sufficient in terms of monitoring.\u201d<\/p>\n<p class=\"c-article-body__text mv-16 l-inset text-pb-8\" data-sophi-feature=\"interstitial\"><a href=\"https:\/\/www.theglobeandmail.com\/canada\/article-despite-approval-from-health-canada-delay-in-cancer-drug-funding\/\" rel=\"nofollow noopener\" target=\"_blank\">Despite approval from Health Canada, delay in cancer drug funding leaves patients in limbo<\/a><\/p>\n<p class=\"c-article-body__text text-pr-5\">Siu hopes SHERLOCK will help build the evidence needed to ease one of the biggest fears of cancer patients: that their cancer will come back. <\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cMost patients, even after curative treatment, whenever they come back to the clinic for a follow-up, I can see that they have fear in their eyes,\u201d she said. <\/p>\n<p class=\"c-article-body__text text-pr-5\">Many breathe a sigh of relief when their CT scans come back clear, she said, but then the anxiety happens all over again at their next scan. <\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201c(They wonder) when am I actually free from having this fear that the cancer will come back?\u201d <\/p>\n<p class=\"c-article-body__text text-pr-5\">Gillian Vandekerkhove, an assistant professor at the University of British Columbia who studies bladder cancer and liquid biopsies, said a lot of research in the field has focused on specific types of cancers. <\/p>\n<p class=\"c-article-body__text text-pr-5\">She welcomed the SHERLOCK trial\u2019s broad focus on multiple types. <\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cThey\u2019re going to provide a wealth of information and biobank samples that researchers can continue to explore,\u201d said Vandekerkhove, who is not involved in the study.<\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cBeing a Canadian-led initiative is really great for Canadian researchers.\u201d<\/p>\n<p class=\"c-article-body__text text-pr-5\">But she also noted the clinical trial has limitations. <\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cI think it\u2019s important to recognize this is an observational study. It\u2019s going to help us understand the technology better and the best-use cases, but there will need to be additional trials. This is not something we\u2019re ready to move into the clinic.\u201d<\/p>\n<p><a style=\"display:block\" href=\"https:\/\/www.theglobeandmail.com\/resizer\/v2\/I6I6DI3U3BGOFBNWMMATHSNYGA.jpg?auth=bd7ed247a5d2fadabb9766962fbebb68fcd15b871aad9917c0d54764111ce9df&amp;width=600&amp;height=400&amp;quality=80&amp;smart=true\" aria-haspopup=\"true\" data-photo-viewer-index=\"0\" rel=\"nofollow noopener\" target=\"_blank\">Open this photo in gallery:<\/a><\/p>\n<p class=\"figcap-text\">Paul Lonergan pictured in 2025 after he was able to return to playing hockey following his cancer treatments.Paul Lonergan\/The Canadian Press<\/p>\n<p class=\"c-article-body__text text-pr-5\">But Paul Lonergan, a 68-year-old Toronto man who was diagnosed with throat cancer about three years ago, believes the research has already paid off for him. <\/p>\n<p class=\"c-article-body__text text-pr-5\">An avid hockey player, Lonergan said his family physician initially thought he had a virus \u2013 but eventually he started \u201ccoughing up blood on the ice.\u201d<\/p>\n<p class=\"c-article-body__text text-pr-5\">After seeing an ear, nose and throat specialist, he was referred to Princess Margaret Cancer Centre and went through radiation and chemotherapy. <\/p>\n<p class=\"c-article-body__text text-pr-5\">Lonergan was also enrolled in a different clinical trial, called the MERIDIAN study, which looked for residual cancer in the blood of patients who had been treated for head and neck cancers. <\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cThe doctor said, \u2018I\u2019ve got good news and a little bit of bad news. The tumour\u2019s gone. There\u2019s fragments of cancer in your blood, which is the bad news, but we have a trial drug that can probably help you,\u2019\u201d he said. <\/p>\n<p class=\"c-article-body__text text-pr-5\">Lonergan was treated for several more months with a new immunotherapy drug as part of the study. <\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cSure as heck it worked,\u201d he said.<\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cI\u2019ve done three six-month checkups and I just finished my third one and they said I\u2019m good.\u201d<\/p>\n<p class=\"c-article-body__text text-pr-5\">Lonergan is still having trouble swallowing and drinks smoothies instead of eating solid food \u2013 but he\u2019s been able to get back on the ice as he slowly recovers. <\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cI don\u2019t care now about being one of the better players or not. I just go out and have fun and exercise and it\u2019s just good to be out and doing that.\u201d<\/p>\n<p class=\"c-article-body__text text-pr-5\">The SHERLOCK study is funded by a $50-million donation from the Peter Gilgan Foundation. <\/p>\n","protected":false},"excerpt":{"rendered":"Researchers at Princess Margaret Cancer Centre in Toronto are working on a large trial to determine if a&hellip;\n","protected":false},"author":2,"featured_media":788172,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[901,888,902,879,877,903,49,48,876,895,896,891,878,875,46,549,295,894,887,914,880,881,893,84,889,890,884,904,885,909,910,912,907,911,905,908,882,898,899,714,897,906,865,61,900,892,886,883,913],"class_list":["post-788171","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-alberta","tag-arts-news","tag-bc","tag-breaking-news","tag-breaking-news-video","tag-british-columbia","tag-ca","tag-canada","tag-canada-news","tag-canada-sports","tag-canada-sports-news","tag-canada-trafficcanada-weather","tag-canadian-breaking-news","tag-canadian-news","tag-economy","tag-education","tag-environment","tag-federal-government","tag-foreign-news","tag-globe-and-mail","tag-globe-and-mail-breaking-news","tag-globe-and-mail-canada-news","tag-government","tag-health","tag-life-news","tag-lifestyle","tag-local-news","tag-manitoba","tag-national-news","tag-new-brunswick","tag-newfoundland-and-labrador","tag-northwest-territories","tag-nova-scotia","tag-nunavut","tag-ontario","tag-pei","tag-photos","tag-political-news","tag-political-opinion","tag-politics","tag-politics-news","tag-quebec","tag-sports-news","tag-technology","tag-travel","tag-trudeau","tag-us-news","tag-world-news","tag-yukon"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/788171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=788171"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/788171\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/788172"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=788171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=788171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=788171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}